Global Site Settings

<p>Earnings announcement for the 3rd quarter FY2022 (Feb 2, 2023)</p>


A passion for sustainability is driving industry-leading CO2 savings in Austria

<p><a class="chevron-after" href="https://www.takeda.com/newsroom/" target="_blank">GO TO NEWSROOM</a><strong><span class="red-text"><br /></span></strong></p>

RECENT NEWS

<p>TSE Code 4502<br />TSE Prime Market<a><br /></a></p>

STOCK PRICE

Andy Plump discusses maintaining trust in science.

<span class="active">Corporate Responsibility</span>

<table style="width: 100%; border-collapse: collapse; border-style: hidden; height: 194px;" border="0">
<tbody>
<tr style="height: 118px; background-color: #edf2f4;">
<td style="width: 100%; height: 118px; padding: 30px;">
<h4><a href="https://www.takeda.com/investors/financial-results/">Earnings announcement for the 3rd quarter FY2022 (February 2, 2023<span class="chevron-after" style="position: relative;">)</span></a></h4>
</td>
</tr>
<tr style="height: 40px;">
<td style="width: 100%; height: 40px; padding: 30px;">
<h4><span class="chevron-after" style="position: relative;"><a href="https://www.takeda.com/investors/ir-events/">41<sup>st</sup> Annual J.P. Morgan Healthcare Conference (4:30pm &ndash; 5:10pm PST on January 9, 2023)</a></span></h4>
</td>
</tr>
<tr style="height: 18px; background-color: #edf2f4;">
<td style="width: 100%; height: 18px; padding: 30px;">
<h4><span class="chevron-after" style="position: relative;"><a href="https://www.takeda.com/investors/shareholders-meetings/">146th Ordinary General Meeting of Shareholders (June 29, 2022)</a></span></h4>
</td>
</tr>
<tr style="height: 18px;">
<td style="width: 100%; height: 18px; padding: 30px;">
<h4><span class="chevron-after" style="position: relative;"><a href="https://www.natpara.com/recall#/latest-updates">Information for US Patients Regarding the NATPARA Recall in the US</a></span></h4>
</td>
</tr>
<tr style="height: 18px; background-color: #edf2f4;">
<td style="width: 100%; height: 18px; padding: 30px;">
<h4><span class="chevron-after" style="position: relative;"><a href="https://www.takeda.com/investors/stock-and-shares/procedure/">ADS Helpline</a></span></h4>
</td>
</tr>
</tbody>
</table>
<p>&nbsp;</p>

Thank you for subscribing.
Please check your inbox to verify your email address.

**Help us understand more about you and what you need.**  
Complete a short survey and share your communication preferences.

[Share your thoughts >](/investors/retail-investors/ri-survey)

<p style="text-align: right;">Takeda's focus on health equity; Rare Disease Day 2023</p>


<h4 style="text-align: center;">Welcome to the Global<br>Corporate Website for Takeda</h4>

If you are looking for specific information,
please visit our country/region website. 



HOME

T-CiRA

About T-CiRA

Leaders Message

What we do

Portfolios

Projects

Inside T-CiRA

Research Achievements

Future of iPSC

What We Do

Newsroom

The research publication of the iPS cell-derived pancreatic islet cell therapy for type 1 diabetes project

<p>The research publication of the <a href="https://assets-dam.takeda.com/raw/upload/v1675193263/legacy-dotcom/siteassets/system/what-we-do/t-cira/research/taro-toyoda_ever2.pdf" target="_blank" rel="noopener">iPS cell-derived pancreatic islet cell therapy for type 1 diabetes project</a> in T-CiRA Joint Program were published <a href="https://diabetes.diabetesjournals.org/content/early/2020/01/29/db19-0728" target="_blank" rel="noopener">online in the Diabetes</a> on January 31st 2020.<br /><br />Paper Details</p>
<ul>
<li>Journal: Diabetes</li>
<li>Title: Insulin-Deficient Diabetic Condition Upregulates the Insulin-Secreting Capacity of Human Induced Pluripotent Stem Cell-Derived Pancreatic Endocrine Progenitor Cells After Implantation in Mice</li>
<li>Authors: Taisuke Mochida<sup>1,3</sup>, Hikaru Ueno<sup>1,3</sup>, Noriko Tsubooka-Yamazoe<sup>1,3</sup>, Hideyuki Hiyoshi<sup>1,3</sup>, Ryo Ito<sup>1,3</sup>, Hirokazu Matsumoto<sup>1,3</sup>, Taro Toyoda<sup>2,3</sup></li>
<li>Author Affiliations:</li>
</ul>
<ol>
<li>T-CiRA Discovery, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa, Japan.</li>
<li>Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.</li>
<li>Takeda-CiRA Joint Program for iPS Cell Applications (T-CiRA), Fujisawa, Kanagawa, Japan</li>
</ol>

Global News Releases

<p><small>HTTP 404 Error</small></p>
<p>We're sorry, the page you are looking for can't be found.</p>
<hr />
<p>&nbsp;</p>
<p style="display: inline-block;"><a title="HOME PAGE" href="https://www.takeda.com/" target="_top">HOME&nbsp;</a>&nbsp;|&nbsp;<a title="CONTACT US" href="https://www.takeda.com/who-we-are/contact-us/" target="_top">CONTACT US</a>&nbsp;|</p>
<a href='https://www.takeda.com/worldwide/' class='countryselector__url'><svg class='footer__country__icon icon__text icon--red'><use xlink:href='/Themes/Shared/ui/svg/takeda.svg#icon-earth'></use></svg>SELECT A COUNTRY SITE</a>
<div class="page-layout--iefix">&nbsp;</div>

Search

Greetings,

I found this interesting and I would like to share it with you.



<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-K75R39" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>


<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5XBTH5B"
height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>

version

website_name

cluster

page_id

page_name

page_language

page_type

page_url

section

page_error

target_group

ip_address

Exceeds limit of {0}MB. Please lower the size for upload.